EP0188599A1 - Verfahren und vorrichtung zum filtern von teilchenmaterial aus flüssigkeiten von medizinischem interesse sowie deren prüfung - Google Patents

Verfahren und vorrichtung zum filtern von teilchenmaterial aus flüssigkeiten von medizinischem interesse sowie deren prüfung

Info

Publication number
EP0188599A1
EP0188599A1 EP19850903907 EP85903907A EP0188599A1 EP 0188599 A1 EP0188599 A1 EP 0188599A1 EP 19850903907 EP19850903907 EP 19850903907 EP 85903907 A EP85903907 A EP 85903907A EP 0188599 A1 EP0188599 A1 EP 0188599A1
Authority
EP
European Patent Office
Prior art keywords
pouch
filter
specimen
compartment
filtration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850903907
Other languages
English (en)
French (fr)
Inventor
Charles B. Beal
C. Bruce Fields
David L. Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INTERNATIONAL HEALTH SERVICES Inc
Original Assignee
INTERNATIONAL HEALTH SERVICES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INTERNATIONAL HEALTH SERVICES Inc filed Critical INTERNATIONAL HEALTH SERVICES Inc
Publication of EP0188599A1 publication Critical patent/EP0188599A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/505Containers for the purpose of retaining a material to be analysed, e.g. test tubes flexible containers not provided for above
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0481Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure squeezing of channels or chambers

Definitions

  • This invention finds application on the examination of fluids of biomedical interest for selected particulate matter. These applications, include but are not limited to, the examination of blood, urine, and fecal suspensions for human or microbial cells, or for parasitic organisms, and of air and drinking water samples for pollen and bacteria.
  • This invention relates in general to new and useful Improvements in a flexible, disposable, plastic fluid collection pouch in which, in a simple manner, a specimen is passed through one or more filters and the residue and/or filtrate is analyzed. Filtration is aided and accelerated by rolling the pouch whereby fluid flow through the filters is maintained. Additionally, the residue or filtrate may be treated within the pouch by one or more selected materials contained separately within the pouch and the treated or untreated filtrate inspected, analyzed and/or microscopically viewed from within the pouch. Permanent and temporary seals of flexible plastic film form the chambers and containers of substances for treatment of the specimen filter residue and filtrate. A portion of the flexible plastic may be transparent in order to provide for visual control processing or analysis.
  • the treatment and analysis of a collected specimen poses a number of problems related to its exposure to the outside environment and to its transfer to different containers. There is retention of a portion of the specimen by the surfaces of the collection pouch as when a viscous liquid is poured from a collection chamber into a receptacle.
  • the specimen is adulterated by substances within or adhering to the surfaces of a receptacle at the time of transfer. Volatile constituents of the specimen are lost with exposure to atmosphere and contents of atmosphere are absorbed by the specimen.
  • Such considerations are of sufficient significance in some instances to require use of "clean rooms" with air cleaning systems and air locks.
  • the specimen may be noxious, lethal or contain irritant or infectious agents requiring special gloved handling in vented or laminar flow hoods.
  • the use of the collection pouch of this invention as the treatment container and the container for viewing and analysis eliminates or greatly reduces many problems associated with transfer of the specimen between containers.
  • Careful preparation of the collection chamber during its manufacture, so as to be free of dust or free of oxygen for example eliminates the necessity of creation of special environments during speciment treatment and analysis in particular instance.
  • the need for specially ventilated space when specimen treatment requires use of noxious or dangerous agents, such as ammonia, or ether is lessened by use of the pouch of this invention. This is because these noxious agents would already be within a closed chamber.
  • Even when specimen loss or adulteration and contamination of the environment is of little significance, the inclusion in the collection pouch of the means of filtration, treatment and analysis considerably decreases costs in comparison with the use of additional containers.
  • the filtrate (either by itself, or on a portion of the filter) is removed from the device and transferred to a microscope slide.
  • the transfer of the specimen for analysis or examination increases the risk of contamination and loss.
  • Rapid particle filtration systems frequently require the use of separate devices and means, for example water pressure, positive or negative air pressure or centrifugation.
  • P.S. Visser and R.J. Pitchford (A Simple Apparatus for Rapid Recovery of Helminth Eggs from Excreta and Special Reference to Schlstosoma mansoni, S.A. Medical Journal, 46: 1344:-1436, 1972) describe a method using water pressure to force matter through a series of filters fixed in a hard-sided cylinder so that a predetermined size of residue is obtained by opening the cylinder to remove the filter and filtrate. This, of course, makes it more difficult or cumbersome to filter particulate matter in the field, since these auxiliary devices and means must be provided.
  • the devices of this invention provide more rapid particle filtration than does gravity filtration without recourse to additional apparatus.
  • Membrane filtration per se and the use of multiple filters for sizing are known. Also, flexible plastic collection pouches have been described. The present invention, however, permits one to rapidly filter particles from a specimen in a flexible plastic pouch in a simple manner.
  • the device of the present invention is versatile in that it is easily adapted to a specific application by provision of appropriate filters and reactants. This versatility reduces the cost of customizing the device to a particular application.
  • Treatment of particles on the surface of a filter for analysis is familiar, for example, C.A. Hunter and R. Burdorff, a Serologic Test for Typhoid Fever, Am. J. Clin. Path., 37: 162-167, 1962.
  • the present invention allows treatment of filtered particles within the collection pouch thereby preventing their exposure to the outside environment.
  • Warren (US 4, 162, 850) describes the filtration of eggs from urine onto a filter, the removal of the filter to a slide, and the transfer of the slide to a microscope for viewing of the particles on the surface of the filter which is wetted to be made transparent.
  • the present invention allows the microscopic viewing of filtered particles through the transparent filter and transparent walls of the flexible plastic collection pouch and thereby preventing its exposure to the outside environment.
  • Nuclepore Corporation markets a "Schisto-kit" incorporating the process of collecting and subsequently viewing particles on a filter membrane made transparent by wetting, which uses increased pressure on the specimen exerted manually by means of a syringe and attached filter-holder chamber.
  • the kit is composed of several separate components and is disassembled to remove the filter and particles to a slide for microscopic viewing and which must be wetted to be viewed. Again, the device of this invention is not disassembled for microscopic viewing of the filtrate.
  • Watanabe US 4, 035, 304, describes a bag-type instrument for filtering the blood to remove denatured blood components and alien substances, utilizing filters having a U-, W-, or S- shape. While Watanabe recognizes that these configurations increase the effective filtering area of the filters, he does not recognize that the pressure distribution varies across these filters or that this feature can be significant in adapting the device to other applications. Additionally, Watanabe does not describe any means for maintaining the flow of blood across the filter other than to suggest that the bag is incorporated in a blood transfusion device and that the flow may be restricted by a clamp. Finally, Watanabe is not concerned with either treatment of the blood components or with their microscopic examination.
  • the invention is a substantially flat, disposable, flexible, transparent plastic pouch, containing one or more filters preferably formed of two main sheets, for specimen processing, including, for example, collection, filtration, treatment and/or analysis (particularly for medical diagnosis) having chambers for collection, viewing, and containment of materials separated by permanent seals, or by frangible sealing means that rupture rapidly but smoothly.
  • One object of the invention is to provide a specimen processing pouch in which a specimen may be rapidly filtered by rolling the bag.
  • Another object of the invention is to provide a specimen processing pouch which prevents large particulate matter from interfering with filtration.
  • Another object of the invention is to provide a specimen processing pouch having chambers containing specimen treatment reagents which are unstable when mixed and are separated until the device is ready for use.
  • Another object of the invention is tp provide a specimen processing pouch in which a sample is progressively driven through a series of filters, to differentiate particles of different sizes.
  • Another object of the invention is to provide a specimen processing pouch having chambers containing reagents separated from the specimen and one another for treatment of particles before or after they are isolated by filtration.
  • Another object of the invention is to provide a specimen processing pouch which is at least partially transparent to facilitate observation of the specimen, or to facilitate observation of the isolated particles, or to facilitate observation of the reaction of analytical reagents with the specimen or isolated particles.
  • Another object of the invention is to provide a specimen processing pouch which accomodates prefiltration treatment of the specimen by centrifuge.
  • Another object of the invention is to provide a specimen processing pouch which accomodates prefiltration treatment of the specimen by flotation.
  • Another object of the invention is to provide a specimen processing pouch having a filtered sample collection chamber suitable for transport and storage to facilitate additional analysis.
  • Another object of the invention is to provide a specimen processing pouch for the isolation of particles from gases.
  • Another object of the invention is to provide a specimen processing pouch for isolation of particles which may be used thout the need for laboratory facilities or for highly skilled technicians.
  • Another object of the invention is to provide a specimen processing pouch which may be used without transfer of material into or out of other containers.
  • Another object of the invention is to prevent contamination of the environment, other parties, or the operator.
  • the invention open to receive the specimen
  • filter residue refers to the material retained by a filter
  • filtrate refers to the material passed by a filter
  • the pouch of this invention is easily adapted to permit examination of either filtrate or filter residue, or both, depending on interest.
  • reactant is used in a broad sense to encompass not merely agents that actually react chemically with a substrata but any agent that alters a physical or chemical property of its substrate.
  • the device in its preferred embodiment is illustrated in Figure 1 and is a nearly rectangular, flexible pouch, preferably constructed of transparent plastic film approximately 0.004 inch in thickness.
  • the pouch is divided into three sections, the upper specimen compartment (7) separated from the central section by an horizontal frangible seal (8) which is a nonpermanent seal joining the upper and under leaves of the pouch. Below the central section is the filtrate compartment (13), terminating in a sealed point, the outlet (14).
  • a membrane filter (9) of a defined pore size.
  • the filter is folded so as to form a V-shape in cross-section, and its upper free margins are attached to the corresponding upper and lower leaves each by a horizontal filter seal (10).
  • the lateral borders of the membrane filters are each sealed to their opposite halves as well as to the perimeter seal each by a lateral filter seal (11).
  • An additional filter is similarly attached to the pouch below the first one and has a smaller pore size than the one above it.
  • a filter reduction seal (12) begins at the perimeter seal on each side, just below the upper filter, and obliquely downwards and inwards to terminate just below the lower filter. This seal joins the upper and under leaves of the pouch, encompassing the filter.
  • the foil strips are bent outwards and the aperture is extended.
  • the specimen to be tested is placed in the specimen compartment.
  • the pouch then is sealed by rolling down the upper end of the pouch by rotating downwards the foil strip.
  • the ends of the foil may be bent over to encompass the roll, holding it in place.
  • Continued pressure exerted by further firm rolling of the pouch forces the specimen through all of the filter, leaving on the upper surface of each filter particles that are too large to pass through.
  • the effective filtration area of the lower two filters is contained within the filter reduction seals.
  • the filtrate passes into the waste compartment. If it is desired to remove the filtrate from the pouch, the outlet may be opened by cutting the plastic.
  • the outlet may be resealed simply by rolling upwards the lower end of the pouch on the lower foil strip.
  • the particles retained on the filters may be viewed directly through the transparent pouch.
  • the filters being transparent, allow direct light microscopy to be used. In viewing the particles across the V-shaped filter, the particles are concentrated since two layers of filter are being observed simultaneously.
  • a specific application of the concept of the device of the preferred embodiment is in the performance of urinalysis for parasite ova, such as in detection of schistosomiasis.
  • Ten ml of urine is collected in the premeasured specimen compartment and the pouch sealed by rolling the foil strips downwards. The continued rolling action ruptures the frangible seal and rapidly forces the urine through both filters down into the waste chamber.
  • the upper filter is a 100 micron pore size polyester fiber weave while the lower filter is a 12 micron pore size filter membrane which is transparent when wet.
  • the 30-70 micron in diameter schistosome ova may be microscopically viewed through the lower filter 1-2 minutes after sample collection.
  • FIG. 2 A modification of the preferred embodiment to stain blood cells in urine is shown in Figure 2.
  • a bladder (16) Within the specimen compartment is a bladder (16), consisting of a small, flexible pouch attached to the upper part of the under leaf by a seal, the bladder attachment (17). Liquid contained within the bladder is the specimen diluting fluid (18). The bladder is closed across its lower margin by the bladder frangible seal (19).
  • the bladder contains a stain that selectively stains polymorphonuclear leukocytes (white blood cells of the granulocyte series).
  • This modification contains three filters, and a grid (15) is imprinted on the middle one. The grid consists of narrowly spaced horizontal and vertical lines.
  • FIG. 3 A modification of the preferred embodiment for isolation and identification of protozoal and helminthic parasites in blood is illustrated in Figure 3.
  • the perimeter seal (3) extends across the top encompassing a small nozzle as an aperture adaptation (21). One end is closed with a latex cap (22) and the other end is continuous with the combined bladder and specimen compartment (20).
  • the bladder (20) terminates in a bladder frangible seal (19).
  • a single wedge-shaped filter (9) of 10 micron pore size is used.
  • the lower diagonal edges of the membrane are fixed to the under leaf (1) by the filter reduction seals (12).
  • the horizontal edge of the wedge is fixed to the upper leaf (2) by the horizontal filter seal (10).
  • a specific use of the modification for isolation of blood parasites is for detecting the presence of mlcrofllaria.
  • the latex cap (22) may be removed or a hypodermic needle used to penetrate it to inject 0.5 ml of blood through the nozzle aperture adaptation (21) and into the bladder (20).
  • the bladder contains a blood cell lysing agent and differential stain. Optimal staining requires a 2-3 minute pause after which the bladder frangible seal (19) is opened by externally applied pressure and the blood passes through the filter leaving the mlcrofllaria as a residue.
  • the wedge filter concentrates the residue at the vertex of the wedge.
  • the organisms may be microscopically identified.
  • a modification of the preferred embodiment for filtration of selected particles from stool samples is shown in Figure 4.
  • a combined bladder and specimen compartment (20) with a bladder frangible seal (19) and containing a diluting fluid (18) has an aperture (4).
  • a horizontal frangible seal (8) separates the specimen compartment (20) from the filtration system.
  • the trough-shaped inherent prefilter (23) is formed of a series of permanent discontinuous seals extending from the perimeter seal of one side of the pouch to that of the other. The inherent prefliter serves to eliminate debris larger than the spaces between the discontinuous seals (e.g., fibrous roughage).
  • a stain e.g., iodine
  • another bladder (16) with bladder frangible seal (19) containing a wash fluid, and followed by a 12 micron pore size membrane filter is another bladder (16) with bladder frangible seal (19) containing a wash fluid, and followed by a 12 micron pore size membrane filter.
  • the waste compartment (13) begins with the inherent retaining filter (24) which is formed of a series of permanent discontinuous seals spaced so as to allow fluid to pass when external pressure is applied but to prevent fluid passing due solely to hydrostatic pressure.
  • An example of its use is for isolation of Schistoaoma mansoni ova from stool.
  • Approximately 1 gm of fresh specimen is placed into the collection chamber and the opening sealed closed by tighly folding the foil strips.
  • the bladder is broken, releasing 9 ml of 10% formalin and 1 ml of Triton X-100, so that the diluent can be mixed with the specimen.
  • the formalin preserves the ova while the surfactant decreases adhesions of the specimen to promote mixing.
  • the rolling action is resumed creating increased internal pressure in the collection chamber so that the frangible seal breaks to allow the mixture access to the inherent prefliter.
  • the larger fecal debris will be retained by the inherent filter and the fluid portion forced through it as the rolling action continues.
  • the second bladder contains an iodine stain.
  • the resumed rolling action of the device again increases internal pressure, breaking the bladder frangible seal, and forcing the solution through the 100 micron woven dacron screening filter, which allows the 30-70 micron eggs to pass, and then forces the solution through the 12 micron pore size filter membrane, which retains the iodine stained schistosome eggs.
  • the third bladder containing a washing fluid, is broken as the rolling is continued, until all waste fluid passes through the bottom inherent retainer. The wash removes excess stain and clears the filter for viewing.
  • the inherent retaining filter prevents waste fluid from passing back through the invention since external pressure must be applied to pass fluid through it.
  • a modification of the invention for flotation and subsequent filtration of selected particles from semisolid matter is illustrated in Figure 5.
  • the specimen compartmnet (7) contains a flotation chamber (25) formed by a chamber perimeter seal (26) leaving a decanting port (17) at the top.
  • the flotation chamber is divided by a horizontal frangible seal (8) to retain a flotation solution (28) at its bottom until time of use.
  • a bladder (16) with a bladder frangible seal (19) is positioned beneath the flotation chamber and contains a washing solution.
  • the filtration system consists of a trough- shaped inherent prefliter (23) and two filters with a bladder (16) between, the upper filter having a larger pore size than the lower one. Both filter membranes are attached transversely across the device and have no folds. Their lateral margins are attached at the perimeter seal and the horizontal filter seals to the upper leaf is at a different height from that to the under leaf.
  • the filtration system is separated from the filtrate chamber by an inherent retaining filter (24).
  • a use of the modification for flotation prior to filtration is in isolation and identification of parasite eggs from stool specimen.
  • a one gram specimen is placed into the flotation chamber of the specimen compartment.
  • the foil top (5) then is closed and rolled down to close the decanting aperture (27).
  • the horizontal frangible seal (8) of the flotation chamber is opened by applying pressure to it externally, and the flotation solution and specimen mixed by gentle massage of the pouch.
  • a sugar solution with specific gravity of 1.2 to 1.3 floats Schistosoma mansoni ova while heavier matter settles to the bottom of the chamber.
  • the top of the invention then is unrolled a few turns tq open the decanting aperture (17) and the upper portion of the flotation mixture decanted.
  • the bladder containing a washing solution e.g., Saline
  • a washing solution e.g., Saline
  • the larger particles are retained by the upper filter (80 micron polyester fiber weave) while smaller particles pass on to the lower (12 micron filter membrane) one.
  • Schistosoma mansoni ova are 30-70 micron in diameter and are retained on the lower filter, and the iodine stain released from the last bladder (16) positioned between the two filters aids in their identification.
  • the small size of the gaps in the inherent retaining filter require increased internal pressure for the filtrate to pass through it into the waste chamber. Afterwards, it prevents backwash of the fluid through the device, the residue on the lower membrane filter, including stained parasite ova, may be viewed microscopically for particle identification.
  • Figure 6a shows an alternative modification for increasing the yield of parasite ova from a stool specimen by accomodating centrlfugatlon.
  • the filtration system is similar to that of Figure 4.
  • the specimen compartment (7) and diluting fluid (18) contained by the horizontal frangible seal (8) is similar to Figure 5, as is the existence on one side of the specimen compartment (7) of a decanting port (27) between the perimeter seal (3) and the chamber perimeter seal (26).
  • a suspension fluid is contained by an extension of the chamber perimeter seal (26) and another horizontal frangible seal (8). Between the chamber perimeter seal (26) and the perimeter seal of this side is another decanting port (27).
  • a one gram specimen is intriduced through the opened aperture (4) and placed in the specimen compartment (7).
  • the aperture then is closed and the top of the pouch locked by folding the foil strips (5) downward intp a coil so that the coil encompasses the tops of the chamber perimeter seal (26) and bending the ends of the foil strips back over the coil.
  • the diluting fluid then is released through the frangible seal by applied external pressure, and it is mixed with the specimen by gentle massage.
  • Figure 6b shows the top coiled and sides folded longitudinally. The longitudinal folding creates a columnar shape which is thicker at the top for containing the specimen and fluids. The bottom then is folded upward as shown in
  • the pouch After centrlfugatlon the pouch is unfolded. The top then is uncoiled two turns, but the aperture need not be opened. Care should be taken in decanting the supernatant to distinguish between the two ports.
  • the supernatant is decanted across the top of the horizontal frangible seal (8) containing the suspension fluid and into the decanting port (27) adjacent to it. This decanting port is continuous with the waste chamber and bypasses the filter system.
  • the suspension fluid then is released through the horizontal frangible seal (8) and into the specimen compartment to resuspend the sediment.
  • the resuspended sediment and suspension fluid is decanted through the other decanting port (27a).
  • the pouch is rolled downward to control internal pressure as before.
  • the bladder frangible seal (19) is broken releasing an iodine stain to aid visualization of the schistosome ova trapped on the second filter (9).
  • Figure 7 illustrates the rolling of the invention and the position of a means (external frame) to facilitate microscopic viewing: 7a shows the invention open for receiving the specimen; 7b shows the device closed and rolled downward so that internal pressure forces the specimen through the inherent prefliter and filters; and 7c shows the invention rolled down to force the filtrate through the inherent retaining filter.
  • 7d the invention has been unrolled a few turns in order to position an external frame over a filter for microscopic analysis.
  • the external frame positions the flexible bag on a microscope stage so that it can be accurately maneuvered and focused.
  • the external frame consists of a pair of hinged frames being transparent or containing transparent windows.
  • the pair of frames separated by hinged means to accept and then encompass the width of the flexible bag when closed by means of a clamp.
  • the rigid frame can be accommodated by any standard mechanical microscope stage.
  • the frame also flattens the bag and filter membrane, and restricts the depth of field to allow adequate light transmission and ability to focus on individual cells through the transparent windows within the frame.
  • Figure 7 also illustrates the use of inherent filters as a means of controlling internal pressure and rate of fluid flow.
  • the upper trough-shaped prefliter consisting of wide gaps between discontinuous permanent seals, permits large increases in rate of flow with small increases in internal pressure.
  • the lower retaining filter requires large increases in pressure to yield small increases in rate of fluid flow.
  • the device of the preferred embodiment may vary in its dimensions and the material of which it is constructed.
  • the device and components may be transparent in whole or in part.
  • the configuration and position of compart- ments, chambers, filters, bladders, and seals may vary.
  • This invention may be divided into one or more completely separate pouches, but containing mechanisms for communication between the separate pouches.
  • the illustrated preferred embodiment .and modifications show vertical series of compartments and filters of decreasing pore size in vertical series. Said compartments and filters also may be in horizontal series to accommodate parallel processing of more than one specimen, or in horizontal series to accommodate different processes for a single specimen.
  • the aperture of this invention may be modified to accommodate different means of introducing or extracting materials through it.
  • a wide aperture sealed with foil strips and a narrow aperture with a latex cap were illustrated.
  • Different configurations, attachments and sealing means may be made to accommodate, for example, syringes, needles, pipettes, swabs and open mouth containers, or to collect a specimen from its source.
  • Inherent filters consisting of gaps between discontinuous permanent seals of the leaves of the device may be constructed of different gap and seal lengths and may be positioned at various locations within the device. Inherent filters may compose the only filtration means of this invention. Inherent filters may serve device function in several ways.
  • gap size determines the size of particles retained when they are used as prefilters or filters and the smaller gap sizes retain fluid until a predetermined level of internal pressured is exceeded.
  • the rate of fluid flow at different pressure levels may be controlled by the number of gaps composing the inherent filter, the level of pressure and rate of flow developed within different portions of the device may be predetermined by positioning inherent filters of specific gap sizes and number at different locations within the invention.
  • An example of one such modification is the positioning of a wide gap inherent filter between a fiber filter and a more fragile filter membrane. Rate of fluid flow through the fiber filter may be accelerated by a high level of internal pressure which would burst the fragile filter membrane.
  • an inherent filter is for measuring a liquid specimen. Gap size and spacing may be predetermined to allow liquid to collect before being made to pass through it by application of external pressure or for a particular length of time (e.g., 30 seconds). Liguid volume then is measure by graduated markings on or in the specimen compartment or at other locations within the invention. Another use of inherent filters depends on their configuration.
  • a trough-shaped and a horizontal configuration are illustrated, the trough-shape concentrates increasing amounts of internal pressure at its tip as the device is rolled doward which is useful for extracting fluid and particles from highly fibrous specimen.
  • the horizontal configuration equalizes pressure across its extent.
  • Other useful modifications of inherent filter configurations may be constructed, for example, semicircular, zig-zag, or sawtooth wave forms distribute pressure and concentrate material in different useful patterns.
  • Filters are manufactured of many different materials. Most filter materials may be sealed directly to the flexible plastics composing the invention by means of heat, sonic or radio frequency welds, adhesives, etc. However, some filters seal with difficulty the nature of their material, thickness, or shape. Such filters may be fixed to panels to which they seal or conform the panels sealed in this invention. Filters may be positioned at various locations within this invention. One or more filter materials may be sealed into invention modifications contianlng no, one, or more inherent filters. The filters may be of various dimensions and pore size, and effective filtration area.
  • the preferred embodiment of this invention and its illustrated modifications show filters positioned in different orientations to fluid flow depending on the locations of their filter seals.
  • the preferred embodiment illustrated V-shape and the illustrated modifications show wedge-shape and rectangular configurations oriented transversely to fluid flow. Different locations of horizontal, vertical and reductions seals may be used to produce a variety of different orientations. Examples of such modifications are shown in Figure 8.
  • Figure 8a illustrates a transverse filter with no fold having the horizontal filter seal to the under leaf placed higher on the pouch than the horizontal seal to the upper leaf. In this modification, the lateral margins are encompassed within the perimeter seal.
  • Figure 8b another modification is shown in which the filter Is folded asymetrically, appearing J-shaped in cross-section.
  • the horizontal filter seals are at different positions relative to the pouch but are located so as to create a fold in the filter membrane.
  • the lateral margins are encompassed within the perimeter seal to provide an extensive filtration surface and rate of flow.
  • the lateral margins may be reduced by position- ing one or more filter reduction seals of the upper and lower leaves and encompassing portions of a filter so as to concentrate residue on the encompassed portion.
  • Filters used in this invention may be opaque, translucent, transparent, or become transparent when wet.
  • Grids constructed of lines at various distances from one another may be imprinted on one or more filters, on the under leaf or the upper leaf, or imprinted separately and used in or with this invention for aid in measurement and quantification of particles.
  • Sequestered within the pouch may be a variety of diluents, solvents, detergents, stains, fixatives, nutrients, and other reactants in gaseous, liquid and solid form.
  • Sequestering may be by means of bladders of various sizes and shapes, con- structed of various materials, sealed into or simply placed within this invention. Sequestering may also be by construction of permanent and frangible seals of the leaves and components of the device itself.
  • Frangible seals may be used to sequester materials within the pouch or may be used to confine fluids during filtration or chemical treatments to portions of the pouch.
  • An example of use in confinement of fluid was illustrated in the preferred embodiment, in which the specimen compartment was separated from the filtration system by a frangible seal. The specimen may be measured before filtration to a predetermined volume by filling the specimen compartment prior to breaking the frangible seal. Graduated markings on or in the specimen compartment may be used to aid measurement.
  • the filtrate or waste compartment outlet may be open, enclosed with permanent seals, or temporarily closed by other means until removal of collected material is desired. Compartments closed with permanent seals may be opened by cutting the plastic and resealed. Sealing means may be heat, sonic or other welds, or by glues and adhesive materials applied to the device. Sealing also may be by rolling as illustrated using foil strips, by clamps, or by apertures attached to the device to accommodate other means of filtrate removal. Examples of other means of filtrate removal requiring aperture attachment are for the connection of a second filtration device of this invention or for a syringe, hyperdermic needle, or pipette.
  • the filtrate may be microscopically examined or otherwise visually analyzed.
  • the filtrate may be chemically treated for analysis, as for example with dye indicators of pH or chemical strips contained within the filtrate chamber indicating levels of glucose.
  • Use of the invention of the preferred embodiment and modifications may be repeated if throughly washed and dried between uses.
  • the washing may be done by passing cleansing fluids and rinses into the outlet and out of the aperture, and passing through the filters to clean residue from their surfaces and pores.
  • Attachments may be fixed to the aperture and outlet to facilitate the flow of fluid during washing and rinsing.
  • rupturable compartments of the seals are adapted to be ruptured merely by manually rolling the pouch, further pressure may be exerted by use of conventional roller and winder means.
  • Variations of the invention allow isolation, identification and analysis of particles of selected sizes from liquid and semisolid specimens. Examples of uses are for biological materials and specifically for medical diagnosis.
  • the preferred embodiment and its illustrated modifications are designed for isolation of Schistosome ova from urine or stool or mlcrofllaria from blood samples.
  • the illustrated designs of the invention also show capabilities for urinalysis in the search for other isolated particles such as blood cells and casts.
  • variations of the modifications allow isolation from intestinal specimens of parasites such as roundworms, hookworms and whipworms, and parts of worms such as proglottids of tapeworms, and helminthic larvae such as those of Stranglyloides stercoralls.
  • Variations of modifications also allow isolation of smaller organisms, for example protozoa such as coccidia and giardia, and amebic trophozoites and cysts.
  • protozoa such as coccidia and giardia
  • amebic trophozoites and cysts could be used for dog heartworm or human filarla, or further modified for isolation of protozoa such as malaria and trypano ⁇ omes of African sleeping sickness and of Chagas' disease.
EP19850903907 1984-07-17 1985-07-17 Verfahren und vorrichtung zum filtern von teilchenmaterial aus flüssigkeiten von medizinischem interesse sowie deren prüfung Withdrawn EP0188599A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63182684A 1984-07-17 1984-07-17
US631826 1984-07-17

Publications (1)

Publication Number Publication Date
EP0188599A1 true EP0188599A1 (de) 1986-07-30

Family

ID=24532920

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850903907 Withdrawn EP0188599A1 (de) 1984-07-17 1985-07-17 Verfahren und vorrichtung zum filtern von teilchenmaterial aus flüssigkeiten von medizinischem interesse sowie deren prüfung

Country Status (2)

Country Link
EP (1) EP0188599A1 (de)
WO (1) WO1986000704A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US6645758B1 (en) 1989-02-03 2003-11-11 Johnson & Johnson Clinical Diagnostics, Inc. Containment cuvette for PCR and method of use
US5079170A (en) * 1989-05-18 1992-01-07 Quidel Corporation Method of sample transfer using a filter applicator
JPH0356150A (ja) * 1989-05-18 1991-03-11 Monoclonal Antibodies Inc フィルタ式塗布具の使用方法及びフィルタ式塗布具並びにこれと共に用いられる分析装置を用いて検出する方法及びこの方法のためのサンプル移し変え方法並びに免疫学的検定を行うための組み立て用部品一式
US5114679A (en) * 1990-08-27 1992-05-19 Eastman Kodak Company Method of using a pipette
US5154888A (en) * 1990-10-25 1992-10-13 Eastman Kodak Company Automatic sealing closure means for closing off a passage in a flexible cuvette
EP0693964A1 (de) * 1992-04-23 1996-01-31 Amoco Corporation Geschlossener behälter zur isolation von ziel-molekülen und zur verstärkung
US5290518A (en) * 1992-08-17 1994-03-01 Eastman Kodak Company Flexible extraction device with burstable sidewall
US5840573A (en) * 1994-02-01 1998-11-24 Fields; Robert E. Molecular analyzer and method of use
CA2311501A1 (en) 1997-11-25 1999-06-03 Mosaic Technologies Devices and methods for detecting target molecules in biological samples
DE10011529T1 (de) 1998-05-01 2011-09-01 Gen-Probe Incorporated Automatisches Diagnoseanalysegerät und Verfahren
CN101432698B (zh) 2004-06-07 2012-06-06 伊库姆公司 处理样品的方法
WO2007076483A1 (en) * 2005-12-22 2007-07-05 Hollister Incorporated Point of care physiologic parameter detection system
JP5074485B2 (ja) 2006-05-22 2012-11-14 スリーエム イノベイティブ プロパティズ カンパニー 試料を調製するためのシステム及び方法
NL1033365C2 (nl) * 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
JP5282088B2 (ja) 2007-06-21 2013-09-04 ジェン−プロウブ インコーポレイテッド 処理実行に使用する機器および容器
WO2010080223A1 (en) * 2008-12-18 2010-07-15 3M Innovative Properties Company System and method for preparing samples
US9933425B2 (en) 2014-04-10 2018-04-03 MEP Equine Solutions LLC Method for the quantification of parasite eggs in feces
DE102015216241A1 (de) 2015-08-25 2017-03-02 Bbi-Biotech Gmbh Behälter und Verfahren zur Filtration einer Suspension
CN107271440A (zh) * 2017-07-01 2017-10-20 中山大学 一种寄生虫虫卵的便携式检测装置及方法
IT202000012355A1 (it) * 2020-05-26 2021-11-26 Tecnoline S P A Dispositivo medicale di trattamento di sostanze corporee.
CN114324154A (zh) * 2020-09-30 2022-04-12 阅美测量系统(上海)有限公司 一种分析沉积在滤片上颗粒的方法及其样品制备分析设备

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036894A (en) * 1958-10-22 1962-05-29 Jasper A Forestiere Method of using testing containers
US3476515A (en) * 1966-04-26 1969-11-04 Du Pont Analytical test pack and process for analysis
US3539300A (en) * 1967-10-23 1970-11-10 Schering Corp Body fluid collector and separator having improved flow rate
JPS4923711B1 (de) * 1969-07-08 1974-06-18
US3660033A (en) * 1969-09-29 1972-05-02 Leroy L Schwartz Disposable specimen collection and analysis bag
US3765536A (en) * 1970-11-10 1973-10-16 Pall Corp Blood filter cascade
US3701433A (en) * 1970-11-10 1972-10-31 Pall Corp Filter for use in the filtration of blood
US3819045A (en) * 1971-06-07 1974-06-25 R Greenwald Fecal examination device
US3874851A (en) * 1973-11-15 1975-04-01 Robert John Wilkins Method and apparatus for the detection of microfilariae
JPS544121Y2 (de) * 1974-07-05 1979-02-23
NO760938L (de) * 1975-03-22 1976-09-23 Biotest Serum Institut Gmbh
US4162850A (en) * 1976-03-01 1979-07-31 Case Western Reserve University Field test for Schistosoma eggs
US4025306A (en) * 1976-08-16 1977-05-24 Arnold David Studer Process and apparatus for heartworm microfilariae detection
US4410427A (en) * 1981-11-02 1983-10-18 Donaldson Company, Inc. Fluid filtering device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8600704A1 *

Also Published As

Publication number Publication date
WO1986000704A1 (en) 1986-01-30

Similar Documents

Publication Publication Date Title
EP0188599A1 (de) Verfahren und vorrichtung zum filtern von teilchenmaterial aus flüssigkeiten von medizinischem interesse sowie deren prüfung
CA2085741C (en) Liquid specimen container and attachable testing modules
EP0654972B1 (de) Verfahren und vorrichtung zur gewinnung einlagiger zellkulturen
US5514341A (en) Feces-sampling transport container
US5830359A (en) Method of separating particles from a filter
US3870639A (en) Filtering device
KR100473123B1 (ko) 여과 및 추출 장치와 이를 사용하는 방법
JP6782998B2 (ja) 装置
JP3459923B2 (ja) 複数部位走化性試験装置及び方法
JPH02149321A (ja) フィルタ組立体
EP0468672A1 (de) Urin-Testmodul mit zytologischem Behälter
JP2007518978A (ja) 血漿用オンデマンドチューブ
NZ243478A (en) Strainer for cell or tissue filtration formed from nylon net. (51) c12m1/12;
US6063282A (en) Simultaneous filtration of numerous samples using microfibers
JPH02248836A (ja) 医療診断のために流体から粒子を分離・収集するための方法およびその装置
EP0734768A1 (de) Verfahren zur Bindung eines biologischen Materials
EP1446227A1 (de) Mikrovorrichtung und methode zum vorbereiten von partikeln für die analyse
US6629612B2 (en) Biological filtration station
US20060167380A1 (en) Collection kit for obtaining specimens from urine
JP2665867B2 (ja) 輸送採便容器
JPH0213977Y2 (de)
JP2717621B2 (ja) 輸送採便容器
CA2017084A1 (en) Filter applicator
JP5369111B2 (ja) 物理障壁を含む隔離デバイス
JPH0517653Y2 (de)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19860618

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STEWART, DAVID, L.

Inventor name: BEAL, CHARLES, B.

Inventor name: FIELDS, C., BRUCE